DaVita HealthCare Partners is a leading provider of kidney care services in the United States, offering a comprehensive range of dialysis and related healthcare services for patients with chronic kidney failure and end-stage renal disease. The company operates a vast network of outpatient dialysis centers and provides integrated care management and support for patients through various healthcare services, including nutritional counseling, social services, and patient education. DaVita is committed to improving patient outcomes and enhancing the quality of life for those affected by kidney disease while working closely with healthcare providers, payers, and communities to address the evolving challenges of kidney care. Read More
Wall Street pared early morning gains by midday Monday, as investor caution returned despite a temporary easing in U.S.-China trade tensions. While the initial market reaction was positive, especially in tech, enthusiasm faded as the trading session progressed.
Stay tuned for the market movements in the S&P500 index on Monday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
Let’s dig into the relative performance of DaVita (NYSE:DVA) and its peers as we unravel the now-completed Q4 outpatient & specialty care earnings season.
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices.
But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Let’s dig into the relative performance of agilon health (NYSE:AGL) and its peers as we unravel the now-completed Q4 outpatient & specialty care earnings season.
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities.
However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.
Looking back on outpatient & specialty care stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including U.S. Physical Therapy (NYSE:USPH) and its peers.
Curious about the market action on Wednesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
Since September 2024, DaVita has been in a holding pattern, posting a small loss of 4.3% while floating around $147.02. The stock also fell short of the S&P 500’s 3.7% gain during that period.
David Kostin, the Chief U.S. Equity Strategist of Goldman Sachs (NYSE: GS), has revised his earnings growth forecast, citing a weaker economic outlook, and highlighted a shift in market trends.
CHICAGO and DENVER, Feb. 27, 2025 (GLOBE NEWSWIRE) -- YMCA of the USA (Y-USA), the national resource office for the 2,600+ YMCAs across the country, is excited to expand its collaboration with DaVita, a leading provider of comprehensive kidney care, to advance chronic disease education and prevention for individuals and their families who are either managing or at risk for chronic kidney disease (CKD). CKD disproportionately affects individuals with risk factors such as hypertension and diabetes.
Outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) will be announcing earnings results tomorrow after market close. Here’s what investors should know.
